Latest filing published 03 Jun 2014 for Navidea Biopharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Jerome Pykett: trading record in brief
Mark Jerome Pykett discloses dealings in 3 companies, chiefly Navidea Biopharmaceuticals, Inc., Alseres Pharmaceuticals Inc /DE and Savara Inc. Over a trading history stretching from 24 May 2004 to 1 June 2014, the count stands at 19 filings.
Both buying and selling appear: 9 purchases worth €42k, against 1 sale worth €169k. Sales outweigh purchases by €128k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants. So far in 2014, the count stands at 1 purchase and 1 sale.
A typical purchase (the median) is worth €3,839.
On 3 June 2014 came the latest disclosure, a share grant in Navidea Biopharmaceuticals, Inc. The clock since the last published purchase (13 May 2014) now reads 4,562 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Jerome Pykett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001225208-14-014295:0
- 10,000 shares@ US$1.34Common StockSEC:0001225208-14-012886:0Canonical exit: 7 Aug 2014 (T+90)
- 120,000 shares@ US$1.96Common StockSEC:0001225208-14-008078:0
- 10,900 shares@ US$1.35Common StockSEC:0001225208-13-023142:0Canonical exit: 6 Feb 2014 (T+90)
- 34,074 shares@ US$3.08Common StockSEC:0001225208-13-008445:0
- 175,000 shares0Common StockSEC:0001225208-13-008446:0
- 58,302 shares@ US$3.16Common StockSEC:0001225208-13-008446:1
- 1,850 shares@ US$2.70Common StockSEC:0001225208-13-007844:0Canonical exit: 13 Jun 2013 (T+90)
- 125,000 shares0Common StockSEC:0001225208-13-007804:0
- 43,236 shares@ US$3.16Common StockSEC:0001225208-13-007804:1
- 35,000 shares@ US$3.08Common StockSEC:0001225208-13-004545:0
- 4,000 shares@ US$2.64Common StockSEC:0001225208-12-019611:0Canonical exit: 10 Dec 2012 (T+90)
- 300,000 shares0Common StockSEC:0001225208-12-004959:0
- 2,700 shares@ US$2.61Common StockSEC:0001225208-11-020385:0Canonical exit: 20 Nov 2011 (T+90)
- 500 shares@ US$2.60Common StockSEC:0001225208-11-020385:1Canonical exit: 20 Nov 2011 (T+90)
- 100 shares@ US$2.56Common StockSEC:0001225208-11-020385:2Canonical exit: 20 Nov 2011 (T+90)
- 1,100 shares@ US$2.56Common StockSEC:0001225208-11-020385:3Canonical exit: 20 Nov 2011 (T+90)
- 500 shares@ US$2.08Common StockSEC:0001209191-08-024280:0Canonical exit: 22 Aug 2004 (T+90)
- 6,777 shares0Common StockSEC:0001209191-08-000679:0
19 of 19 declarations
